Jefferies Financial Group Reiterates “Hold” Rating for IGM Biosciences (NASDAQ:IGMS)

IGM Biosciences (NASDAQ:IGMS – Get Free Report)‘s stock had its “hold” rating reiterated by Jefferies Financial Group in a report released on Friday,Benzinga reports. They currently have a $2.00 target price on the stock, down from their previous target price of $48.00. Jefferies Financial Group’s price target would suggest a potential downside of 4.76% from […]

Leave a Reply

Your email address will not be published.

Previous post Trump can still vote after sentencing, but can’t own a gun and will have to turn over DNA sample
Next post Brian J. Cali Buys 225 Shares of Fidelity D & D Bancorp, Inc. (NASDAQ:FDBC) Stock